Vir Biotechnology (VIR)
US Market

Vir Biotechnology (VIR) Stock Price & Analysis


VIR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.05 - $31.78
Previous Close$26.05
Average Volume (3M)938.51K
Market Cap
Enterprise Value$1.37B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$121.46M
Price to Earnings (P/E)-23.8
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding133,976,538
10 Day Avg. Volume876,950
30 Day Avg. Volume938,510
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)1.83
Price to Sales (P/S)74.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.75
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda-4.13
Price Target Upside88.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vir Biotechnology’s price range in the past 12 months?
Vir Biotechnology lowest stock price was $18.05 and its highest was $31.78 in the past 12 months.
    What is Vir Biotechnology’s market cap?
    Currently, no data Available
    When is Vir Biotechnology’s upcoming earnings report date?
    Vir Biotechnology’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
      How were Vir Biotechnology’s earnings last quarter?
      Vir Biotechnology released its earnings results on May 04, 2023. The company reported -$1.06 earnings per share for the quarter, missing the consensus estimate of -$0.875 by -$0.185.
        Is Vir Biotechnology overvalued?
        According to Wall Street analysts Vir Biotechnology’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vir Biotechnology pay dividends?
          Vir Biotechnology does not currently pay dividends.
          What is Vir Biotechnology’s EPS estimate?
          Vir Biotechnology’s EPS estimate is -$1.21.
            How many shares outstanding does Vir Biotechnology have?
            Vir Biotechnology has 133,976,530 shares outstanding.
              What happened to Vir Biotechnology’s price movement after its last earnings report?
              Vir Biotechnology reported an EPS of -$1.06 in its last earnings report, missing expectations of -$0.875. Following the earnings report the stock price went down -3.922%.
                Which hedge fund is a major shareholder of Vir Biotechnology?
                Among the largest hedge funds holding Vir Biotechnology’s share is Perceptive Advisors LLC. It holds Vir Biotechnology’s shares valued at 3M.


                  Vir Biotechnology Stock Smart Score

                  The Vir Biotechnology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vir Biotechnology

                  Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.


                  Top 5 ETFs holding VIR

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  Fidelity Nasdaq Composite Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold VIR. The ETFs are listed according to market value of VIR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intellia Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis